Plus Therapeutics (PSTV) Other Gross PP&E Adjustments (2016 - 2025)
Plus Therapeutics (PSTV) has disclosed Other Gross PP&E Adjustments for 15 consecutive years, with -$20000.0 as the latest value for Q3 2025.
- On a quarterly basis, Other Gross PP&E Adjustments rose 81.13% to -$20000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was -$20000.0, a 81.13% increase, with the full-year FY2024 number at $3.4 million, up 8.91% from a year prior.
- Other Gross PP&E Adjustments was -$20000.0 for Q3 2025 at Plus Therapeutics, up from -$29000.0 in the prior quarter.
- In the past five years, Other Gross PP&E Adjustments ranged from a high of $3.4 million in Q4 2024 to a low of -$638000.0 in Q2 2021.
- A 5-year average of $254888.9 and a median of -$155000.0 in 2024 define the central range for Other Gross PP&E Adjustments.
- Peak YoY movement for Other Gross PP&E Adjustments: crashed 10433.33% in 2022, then soared 129.77% in 2023.
- Plus Therapeutics' Other Gross PP&E Adjustments stood at -$559000.0 in 2021, then skyrocketed by 344.54% to $1.4 million in 2022, then surged by 129.77% to $3.1 million in 2023, then increased by 8.91% to $3.4 million in 2024, then tumbled by 100.58% to -$20000.0 in 2025.
- Per Business Quant, the three most recent readings for PSTV's Other Gross PP&E Adjustments are -$20000.0 (Q3 2025), -$29000.0 (Q2 2025), and -$38000.0 (Q1 2025).